JR Glynn, K Fielding, T Mzembe, L Sichali… - The Lancet Global …, 2021 - thelancet.com
Background A large, double-blind, randomised, placebo-controlled trial of repeat BCG found
49% efficacy against leprosy but no protection against tuberculosis after 6–9 years' follow-up …